1. Nanomedicine Research Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;
2. Department of Bioscience, Shri Ram Group of College (SRGC), Muzaffarnagar, India;
3. King Abdullah Institute for Nanotechnology, King Saud University, Riyadh, Saudi Arabia;
4. Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia;
5. Department of Pharmacology, College of Medicine, Al-Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia;
6. Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah, Saudi Arabia;
7. School of Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea;
8. College of Medicine and Dentistry, Dar Al Uloom University, Riyadh, Saudi Arabia;
9. Phase I-Early Clinical Trials Unit, Oncology Department and Multidisciplinary Oncology Center Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium